CARLSBAD, Calif., Oct. 01, 2015 (GLOBE NEWSWIRE) — Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that the first patient surgical implantation of the Alphatec Neocore™ Osteoconductive Matrix, a synthetic scaffold for the regeneration of bone, was successfully completed. The Company will be showcasing Alphatec Neocore, as well as its portfolio of products at the upcoming North American Spine Society (NASS) Annual Meeting being held at McCormick Place West, Chicago, Illinois, from October 14th – 16th, 2015. Alphatec Spine will be located in booth number 1147.
“Alphatec Neocore provides surgeons with the handling characteristics and osteoconductive composition they’ve been looking for in bone grafting products,” explains Jim Corbett, President and Chief Executive Officer of Alphatec Spine. “Alphatec Neocore will expand our biologics opportunity —both here in the U.S. and internationally. This exciting new global biologic brand will give us the ability to operate more broadly in the global marketplace, bringing a compelling synthetic bone regeneration solution and competitive pricing to our surgeon and hospital customers worldwide.”
Alphatec Neocore Osteoconductive Matrix is a synthetic scaffold that is designed to provide an effective core environment for bone growth. When hydrated with patient bone marrow aspirate (BMA), Alphatec Neocore becomes a complete bone graft, which possesses all the necessary components of bone growth. Engineered to perform like natural bone, Alphatec Neocore’s composition and porosity provide the benefits of rapid revascularization throughout graft and supports replacement of three-dimensional matrix with healthy new bone growth.
Alphatec Neocore was developed by Thomas T. Haider, M.D., founder of the Haider Spinal Center in Riverside, California. In July, 2015, Alphatec Spine established a global, exclusive development and distribution agreement with Haider Biologics for Alphatec Neocore Osteoconductive Matrix, as well as other future products developed under the agreement. Alphatec Neocore is exclusively distributed through the Alphatec Spine distribution channels.
About Alphatec Spine
Alphatec Spine, Inc., a wholly owned subsidiary of Alphatec Holdings, Inc., is a global medical device company that designs, develops, manufactures and markets spinal fusion technology products and solutions for the treatment of spinal disorders associated with disease and degeneration, congenital deformities and trauma. The Company’s mission is to improve lives by delivering advancements in spinal fusion technologies. The Company and its affiliates market products in the U.S. and internationally via a direct sales force and independent distributors.
Additional information can be found at www.alphatecspine.com.
About the North American Spine Society (NASS)
The North American Spine Society is a global multidisciplinary medical society that utilizes education, research and advocacy to foster the highest quality, ethical, value-based and evidence-based spine care for patients. The society is comprised of almost 9,000 members worldwide from disciplines including orthopedic surgery, neurosurgery, physical medicine and rehabilitation, pain management, physical/occupational therapy, anesthesiology, radiology and other health care professionals focused on the spine.
Additional information can be found at www.nassannualmeeting.org.